ARCHIVES

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | March 13, 2009

Download PDF Visit The Full Archive

Related Articles

Reports: Tobacco Cessation Underused, NIH Panel Says.

June 16, 2006

Funding Opportunities: Lymphoma Fellowship

June 8, 2001

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

ICCCR Loses Support Of French, DeVita Resigns As President, Fischinger To Take Over

July 17, 1992